Search for Clinical Trial Results
Idiopathic Pulmonary Fibrosis - 43 Studies Found
Status | Study |
RECRUITING |
Study Name: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: BBT-877 24 weeks + Follow-up 4 weeks |
COMPLETED |
Study Name: Dose Reduction and Discontinuation With Anti-Fibrotic Medications Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: Pirfenidone |
COMPLETED |
Study Name: Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: Nintedanib |
RECRUITING |
Study Name: A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: Caveolin-1-Scaffolding-Protein-Derived Peptide |
RECRUITING |
Study Name: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: PLN-74809 |
RECRUITING |
Study Name: Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: Dietary Supplement: EGCG Capsules with Teavigo EGCG (at least 94% purity).300 mg EGCG (2 capsules) taken orally daily for 12 weeks.Dru |
RECRUITING |
Study Name: Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: Orally via a tablet. |
RECRUITING |
Study Name: A Study to Investigate Leramistat in Patients With IPF Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: Drug: Leramistat |
RECRUITING |
Study Name: A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: Vixarelimab will be administered as per the schedule specified in the respective arms. |
COMPLETED |
Study Name: Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2024-05-20 Interventions: A 20-30 minutes low-medium intensity aerobic exercise training with cycling ergometer. |